"TBSF" (20%) Human Albumin Solution

Země: Austrálie

Jazyk: angličtina

Zdroj: Department of Health (Therapeutic Goods Administration)

Aktivní složka:

Albumin, Quantity: 200 g/L

Dostupné s:

CSL Behring Australia Pty Ltd

INN (Mezinárodní Name):

Albumin

Léková forma:

Injection, solution

Složení:

Excipient Ingredients: octanoate; sodium

Podání:

Intravenous

Jednotky v balení:

50mL, 100mL

Třída:

Medicine Listed (Export Only)

Druh předpisu:

(S1) This Schedule is intentionally blank

Terapeutické indikace:

Hypoproteinaemia in the acutely ill patient TBSF (20%) Human Albumin Solution is administered when there are existing or anticipated clinical problems or complications from reduced oncotic pressure, and/or as an adjunct to diuretic therapy. Shock. TBSF (20%) Human Albumin Solution may be used for the resuscitation of patients in shock due to acute loss of blood or plasma, but 4 - 5% human albumin is preferred when available. Burns. Extensive burns are followed by sequential shifts in the distribution of body water, salt and proteins resulting in hypovolaemic shock and circulatory failure.

Přehled produktů:

Visual Identification: Clear, slightly viscous almost colourless, yellow or green; Container Type: Vial; Container Life Time: 4 Years; Container Temperature: Store below 30 degrees Celsius

Stav Autorizace:

Listed (Export Only)

Datum autorizace:

2006-03-01